Supreme Court Invites Government Response To Generic Drug Patent Petition
WASHINGTON, D.C. — The U.S. Supreme Court on June 23 invited the government to express its views on a petition for a writ of certiorari filed by a bioequivalent drug manufacturer...To view the full article, register now.
Already a subscriber? Click here to view full article